Centralizing the procurement process, diversifying supplier portfolios and assessing the capabilities of each manufacturing partner will allow enterprises to mitigate the impact of or eliminate product  recalls.
In 1982, 31 million bottles of Johnson & Johnson's Tylenol were recalled, costing the company more than $100 million. An order for the bottles to be returned was incited after seven people around in the Greater Chicago area were killed after consuming tablets laced with potassium cyanide.
Bridgestone/Firestone recalled an estimated 6.5 million tires after Ford Explorers and Mercury Mountaineers equipped with those tires experienced tread separation. Not only did Bridgestone spend $440 million on the ordeal, Ford's bill amounted to a whopping $3 billion, not including the $600 million in lawsuits incited by individuals who either sustained major injuries themselves as a result of the tires or were taking legal action on behalf of deceased relatives.
In 2004, Merck, a pharmaceutical company, recalled arthritis drug Vioxx after research discovered that people who had been taking the drug for at least 18 months were likely to suffer heart attacks and strokes. First, Merck